净收入 更改
AstraZeneca USD 2.51B 573M 2026-06
Genmab DKK 303M 250M 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
GRIFOLS EUR 154M 81M 2026-06
Hikma Pharmaceutical USD 164M 45M 2025-12
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Qiagen NV USD 103.4M 35.36M 2026-06
UCB EUR 1.08B 608M 2025-12